Cargando…
Symptomatology of carbamazepine‐ and oxcarbazepine‐induced hyponatremia in people with epilepsy
OBJECTIVE: To ascertain whether adverse effects experienced by people taking carbamazepine or oxcarbazepine could be attributed to carbamazepine‐ or oxcarbazepine‐induced hyponatremia (COIH). METHODS: We performed an observational study, collecting data between 2017 and 2019 on serum sodium levels a...
Autores principales: | Berghuis, Bianca, Hulst, Janic, Sonsma, Anja, McCormack, Mark, de Haan, Gerrit‐Jan, Sander, Josemir W., Lindhout, Dick, Koeleman, Bobby P. C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8248112/ https://www.ncbi.nlm.nih.gov/pubmed/33576502 http://dx.doi.org/10.1111/epi.16828 |
Ejemplares similares
-
A genome‐wide association study of sodium levels and drug metabolism in an epilepsy cohort treated with carbamazepine and oxcarbazepine
por: Berghuis, Bianca, et al.
Publicado: (2019) -
Oxcarbazepine and Hyponatremia
por: Čiauškaitė, Julija, et al.
Publicado: (2022) -
Behavioral problems in children of mothers with epilepsy prenatally exposed to valproate, carbamazepine, lamotrigine, or levetiracetam monotherapy
por: Huber‐Mollema, Yfke, et al.
Publicado: (2019) -
Oxcarbazepine-induced hyponatremia: A case report
por: Pinto, M. Barbosa, et al.
Publicado: (2021) -
Hyponatremia from oxcarbazepine: A case report
por: Coucheiro Limeres, P., et al.
Publicado: (2022)